REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lekaren Tilia Pharm, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Miscellaneous Store Retailers | Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Lekaren Tilia Pharm, S.R.O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lekaren Tilia Pharm, S.R.O. is based in Slovakia. The head office is in Surany. It operates in the Pharmacies and Drug Stores sector. It was first established on January 28, 2006. Lekaren Tilia Pharm, S.R.O. currently employs 5 - 9 (2025) people. There was a net sales revenue drop of 0.03% reported in Lekaren Tilia Pharm, S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 8.77%. The net profit margin of Lekaren Tilia Pharm, S.R.O. increased by 1.28% in 2024.

Headquarters
Nabrezie 28
Surany; Nitriansky; Postal Code: 94201

Contact Details: Purchase the Lekaren Tilia Pharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Lekaren Tilia Pharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Lekaren Tilia Pharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Lekaren Tilia Pharm, S.R.O. report to view the information.
Incorporation Date:
January 28, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lekaren Tilia Pharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.03%▼
Total operating revenue
0.5%▲
Operating profit (EBIT)
33.13%▲
EBITDA
16.51%▲
Net Profit (Loss) for the Period
31.84%▲
Total assets
-8.77%▼
Total equity
-0.52%▼
Operating Profit Margin (ROS)
1.59%▲
Net Profit Margin
1.28%▲
Return on Equity (ROE)
3.74%▲
Debt to Equity Ratio
-0.17%▼
Quick Ratio
3.42%▲
Cash Ratio
1.31%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo